JP2005023085A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005023085A5 JP2005023085A5 JP2004261714A JP2004261714A JP2005023085A5 JP 2005023085 A5 JP2005023085 A5 JP 2005023085A5 JP 2004261714 A JP2004261714 A JP 2004261714A JP 2004261714 A JP2004261714 A JP 2004261714A JP 2005023085 A5 JP2005023085 A5 JP 2005023085A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/121,105 US6448379B1 (en) | 1993-09-14 | 1993-09-14 | IL8 inhibitors |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7509317A Division JPH09502725A (ja) | 1993-09-14 | 1994-09-13 | Il8阻害剤 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008066818A Division JP2008169227A (ja) | 1993-09-14 | 2008-03-14 | Il8阻害剤 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2005023085A JP2005023085A (ja) | 2005-01-27 |
JP2005023085A5 true JP2005023085A5 (ja) | 2005-09-02 |
JP4122321B2 JP4122321B2 (ja) | 2008-07-23 |
Family
ID=22394586
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7509317A Withdrawn JPH09502725A (ja) | 1993-09-14 | 1994-09-13 | Il8阻害剤 |
JP2004261714A Expired - Fee Related JP4122321B2 (ja) | 1993-09-14 | 2004-09-08 | Il8阻害剤 |
JP2008066818A Withdrawn JP2008169227A (ja) | 1993-09-14 | 2008-03-14 | Il8阻害剤 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7509317A Withdrawn JPH09502725A (ja) | 1993-09-14 | 1994-09-13 | Il8阻害剤 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008066818A Withdrawn JP2008169227A (ja) | 1993-09-14 | 2008-03-14 | Il8阻害剤 |
Country Status (11)
Country | Link |
---|---|
US (2) | US6448379B1 (ja) |
EP (3) | EP1932856A3 (ja) |
JP (3) | JPH09502725A (ja) |
AT (2) | ATE229036T1 (ja) |
AU (1) | AU697190B2 (ja) |
CA (1) | CA2171289C (ja) |
DE (2) | DE69435083T2 (ja) |
DK (1) | DK1283217T3 (ja) |
ES (1) | ES2302774T3 (ja) |
PT (1) | PT1283217E (ja) |
WO (1) | WO1995007934A2 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997000893A1 (en) * | 1995-06-20 | 1997-01-09 | Chiron Corporation | Interleukin-8 receptor binding compounds |
US7083983B2 (en) | 1996-07-05 | 2006-08-01 | Cancer Research Campaign Technology Limited | Inhibitors of the interaction between P53 and MDM2 |
AU777766B2 (en) * | 1996-07-05 | 2004-10-28 | Cancer Research Technology Limited | Inhibitors of the interaction between p53 and MDM2 |
JP2000516620A (ja) * | 1996-08-15 | 2000-12-12 | スミスクライン・ビーチャム・コーポレイション | Il―8レセプターアンタゴニスト |
AU7127298A (en) * | 1997-04-14 | 1998-11-11 | Emory University | Serine protease inhibitors |
ES2156534B1 (es) * | 1999-02-03 | 2002-02-01 | Smithkline Beecham Sa | Nuevos inhibidores de la interaccion entre la interleuquina-8 y sus receptores |
WO2001072830A2 (de) * | 2000-03-31 | 2001-10-04 | Ipf Pharmaceuticals Gmbh | Diagnostik- und arzneimittel zur untersuchung des zelloberflächenproteoms von tumor- und entzündungszellen sowie zur behandlung von tumorerkrankungen und entzündlichen erkrankungen vorzugsweise mit hilfe einer spezifischen chemokinrezeptor-analyse und der chemokinrezeptor-ligand-interaktion |
NZ541050A (en) * | 2002-12-16 | 2010-06-25 | Genmab As | Human monoclonal antibodies against interleukin 8 (IL-8) |
CL2008001071A1 (es) * | 2007-04-17 | 2009-05-22 | Smithkline Beecham Corp | Metodo para obtener anticuerpo penta-especifico contra il-8/cxcl8, gro-alfa/cxcl1, gro-beta/cxcl2), gro-gama/cxcl3 y ena-78/cxcl5 humanas; anticuerpo penta-especifico; proceso de produccion del mismo; vector, hbridoma o celela que lo comprende; composicion farmceutica; uso para tratar copd, otras enfermedades. |
BR112013011003B1 (pt) | 2010-11-08 | 2021-12-07 | Novartis Ag | Polipeptídeo e seus usos, célula hospedeira transgênica de microrganismo, nanocorpo monovalente, bivalente, multivalente, biparatópico ou multiparatópico, e composição farmacêutica |
US9328174B2 (en) | 2012-05-09 | 2016-05-03 | Novartis Ag | Chemokine receptor binding polypeptides |
EP2869818A1 (en) | 2012-07-06 | 2015-05-13 | Novartis AG | Combination of a phosphoinositide 3-kinase inhibitor and an inhibitor of the il-8/cxcr interaction |
US11291641B2 (en) * | 2016-10-03 | 2022-04-05 | The Children's Medical Center Corporation | Prevention and treatment of diabetic nephropathy |
JP2021510697A (ja) | 2018-01-12 | 2021-04-30 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | がん処置のための坑il−8抗体及び坑pd−1抗体を用いる組合せ治療 |
JP7429427B2 (ja) | 2020-01-31 | 2024-02-08 | 株式会社大都技研 | 抽出装置 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ207394A (en) * | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
IE913192A1 (en) | 1990-09-12 | 1992-02-25 | Scripps Research Inst | Active site of interleukin-8: polypeptide analogs and¹antibodies |
JP2866182B2 (ja) | 1990-10-08 | 1999-03-08 | 日本ケミファ株式会社 | エンドセリン受容体 |
US5440021A (en) * | 1991-03-29 | 1995-08-08 | Chuntharapai; Anan | Antibodies to human IL-8 type B receptor |
US5571702A (en) * | 1991-03-29 | 1996-11-05 | Genentech, Inc. | Amplification method for detection of human PF4A receptors |
CA2107682A1 (en) * | 1991-04-10 | 1992-10-11 | Javier Navarro | Interleukin-8 receptors and related molecules and methods |
US5374506A (en) * | 1991-09-13 | 1994-12-20 | The United States Of America As Represented By The Department Of Health And Human Services | Amino acid sequence for a functional human interleukin-8 receptor |
-
1993
- 1993-09-14 US US08/121,105 patent/US6448379B1/en not_active Expired - Lifetime
-
1994
- 1994-09-13 ES ES02017044T patent/ES2302774T3/es not_active Expired - Lifetime
- 1994-09-13 EP EP08000646A patent/EP1932856A3/en not_active Withdrawn
- 1994-09-13 AU AU78348/94A patent/AU697190B2/en not_active Ceased
- 1994-09-13 JP JP7509317A patent/JPH09502725A/ja not_active Withdrawn
- 1994-09-13 DE DE69435083T patent/DE69435083T2/de not_active Expired - Lifetime
- 1994-09-13 AT AT94929201T patent/ATE229036T1/de not_active IP Right Cessation
- 1994-09-13 WO PCT/US1994/010356 patent/WO1995007934A2/en active IP Right Grant
- 1994-09-13 AT AT02017044T patent/ATE388168T1/de not_active IP Right Cessation
- 1994-09-13 PT PT02017044T patent/PT1283217E/pt unknown
- 1994-09-13 EP EP02017044A patent/EP1283217B1/en not_active Expired - Lifetime
- 1994-09-13 EP EP94929201A patent/EP0719285B1/en not_active Expired - Lifetime
- 1994-09-13 CA CA002171289A patent/CA2171289C/en not_active Expired - Fee Related
- 1994-09-13 DE DE69431843T patent/DE69431843T2/de not_active Expired - Lifetime
- 1994-09-13 DK DK02017044T patent/DK1283217T3/da active
-
1995
- 1995-06-07 US US08/487,795 patent/US6436390B1/en not_active Expired - Lifetime
-
2004
- 2004-09-08 JP JP2004261714A patent/JP4122321B2/ja not_active Expired - Fee Related
-
2008
- 2008-03-14 JP JP2008066818A patent/JP2008169227A/ja not_active Withdrawn